Elite Pharmaceuticals, Inc. (ELTP)
0.2468
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Elite Pharmaceuticals Cash from Operations (TTM) : 19.04M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.04M |
| March 31, 2026 | 23.75M |
| December 31, 2025 | 18.52M |
| September 30, 2025 | 22.73M |
| June 30, 2025 | 19.09M |
| March 31, 2025 | 7.456M |
| December 31, 2024 | 5.598M |
| September 30, 2024 | 4.266M |
| June 30, 2024 | 2.573M |
| March 31, 2024 | -3.282M |
| December 31, 2023 | -2.373M |
| September 30, 2023 | -0.5449M |
| June 30, 2023 | 1.186M |
| March 31, 2023 | 3.339M |
| December 31, 2022 | 1.975M |
| September 30, 2022 | 5.577M |
| June 30, 2022 | 4.235M |
| March 31, 2022 | 6.508M |
| December 31, 2021 | 4.154M |
| September 30, 2021 | 2.355M |
| June 30, 2021 | 4.102M |
| March 31, 2021 | 3.194M |
| December 31, 2020 | 2.737M |
| September 30, 2020 | 1.190M |
| June 30, 2020 | -1.175M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.794M |
| December 31, 2019 | -2.724M |
| September 30, 2019 | -3.680M |
| June 30, 2019 | -4.895M |
| March 31, 2019 | -6.793M |
| December 31, 2018 | -5.670M |
| September 30, 2018 | -4.880M |
| June 30, 2018 | -5.428M |
| March 31, 2018 | -4.809M |
| December 31, 2017 | -7.872M |
| September 30, 2017 | -8.120M |
| June 30, 2017 | -8.211M |
| March 31, 2017 | -7.884M |
| December 31, 2016 | -3.201M |
| September 30, 2016 | -4.259M |
| June 30, 2016 | -5.420M |
| March 31, 2016 | -2.765M |
| December 31, 2015 | -7.228M |
| September 30, 2015 | -8.050M |
| June 30, 2015 | -9.000M |
| March 31, 2015 | -15.10M |
| December 31, 2014 | -12.67M |
| September 30, 2014 | -11.52M |
| June 30, 2014 | -8.020M |
| March 31, 2014 | -4.162M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Nektar Therapeutics | -233.79M |
| Daré Bioscience, Inc. | -11.29M |
| Eton Pharmaceuticals, Inc. | 15.14M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |